Marianna Shafarenko
About Marianna Shafarenko
Marianna Shafarenko is a Senior Director/LCM Lead at Bristol Myers Squibb, specializing in CD19 CAR T liso-cel (JCAR017) in Worldwide Hematology.
Current Role at Bristol Myers Squibb
Marianna Shafarenko currently serves as the Senior Director/LCM Lead for CD19 CAR T liso-cel (JCAR017) across Worldwide Hematology at Bristol Myers Squibb in Summit, NJ. In this role, she focuses on the strategic differentiation and expansion of the liso-cel CAR T program across various B-cell histology indications, including chronic lymphocytic leukemia (CLL), indolent non-Hodgkin lymphoma (iNHL), and mantle cell lymphoma (MCL).
Previous Roles at Bristol Myers Squibb
Marianna Shafarenko has held multiple positions at Bristol Myers Squibb, showcasing her versatility and expertise in the field. From 2018 to 2019, she served as Senior Director/Global Marketing for Early-Phase Assets Lymphoma & Myeloid Programs. Prior to that, from 2012 to 2018, she was the Global Marketing Director for Revlimid's commercial launch in indolent NHL. From 2011 to 2012, she directed Business Intelligence in Market Excellence. In 2010, she was the Interim Director of Disease Lead (CLL) in Global Medical Affairs. From 2009 to 2011, she was the Director of Scientific Communications for Pipeline Indications in Global Medical Affairs.
Early Career in Pharmaceuticals
Before her extensive tenure at Bristol Myers Squibb, Marianna Shafarenko held significant roles in other leading pharmaceutical companies. From 2007 to 2009, she was the Deputy Director of Global Marketing at Bayer Pharmaceuticals. She worked as a Global Medical Affairs Manager at Novartis Pharmaceuticals from 2006 to 2007 and at Berlex Laboratories Inc from 2005 to 2006. Additionally, she served as a Medical Director at New World Health Marketing Education from 2002 to 2005.
Educational Background
Marianna Shafarenko has an impressive academic background. She earned her Doctor of Philosophy (PhD) in Molecular Biology & Genetics from Temple University School of Medicine. Additionally, she holds a Bachelor of Science (BS) in Biology/Biological Sciences, General from Temple University. Her deep technical knowledge has significantly contributed to her expertise in hematologic malignancies.
Industry Contributions and Expertise
Marianna Shafarenko is often the point person for key outside investigators and top-tier Key Opinion Leaders (KOLs) in the lymphoma program. Known for driving cross-functional teams to execute difficult decisions and achieve strategic goals, she has a deep technical expertise in hematologic malignancies. She excels in developing effective commercial strategies and plays a critical role in major decisions such as authorships and collaborations. She is also noted for her practical application of science to benefit patients, significantly impacting the standard of care offered.